Ralph Torbay

Ralph Torbay is Immunocore’s Head of Commercial. Ralph is an experienced commercial leader with a proven track record of successful oncology launches and significant immuno-oncology (IO) experience. Prior to joining Immunocore, Ralph was Global Head of Haematology marketing at AstraZeneca where in addition to helping to build their global Haematology franchise, he launched three major drugs in oncology, including the first checkpoint inhibitor in stage III unresectable NSCLC. Prior to AstraZeneca, Ralph was at Novartis Oncology where he held roles of increasing responsibility within the commercial organization and worked on five products in several disease areas across Haematology and Oncology.

Ralph earned his Masters of Business Administration degree at the Simon Graduate School of Business, University of Rochester; and a Bachelor of Science in Biotechnology from Rochester Institute of Technology.